Universitätsklinikum Schleswig-Holstein (UKSH)

AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022 (2022) Banys-Paluchowski M, Thill M, Kuhn T, Ditsch N, Heil J, Woeckel A, Fallenberg E, et al. Journal article Digital and innovative teaching in dermatology Practically oriented teaching online (2022) Wittbecker LM, Pham C, Wohlgemuth LK, Hoang MA, Bandholz TC, Schuh S, Gihl J, et al. Journal article Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial (2022) Eichinger A, Poetschger U, Glogova E, Bader P, Basu O, Beier R, Burkhardt B, et al. Journal article Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation (2022) Kunadt D, Stasik S, Metzeler KH, Roellig C, Schliemann C, Greif PA, Spiekermann K, et al. Journal article What is walking? a systematic review and meta-ethnography (2022) Delgado Ortiz L, Polhemus A, Keogh A, Sutton N, Remmele W, Hansen C, Kluge F, et al. Conference contribution Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021—a two-round Delphi survey among international experts (2022) Ziehfreund S, Tizek L, Hangel N, Fritzsche MC, Weidinger S, Smith C, Bryce PJ, et al. Journal article Unique characteristics of AQP4-specific T cells in patients with AQP4+neuromyelitis optica spectrum disorder (NMOSD) (2022) Saggau C, Bacher P, Esser D, Leypoldt F, Wandinger KP, Paul F, Martin R, et al. Conference contribution The role of joint-draining lymph node stromal cells in inflammatory arthritis (2022) Schälter F, Azizov V, Frech M, Dürholz K, Sokolova M, Hendel A, Focke K, et al. Conference contribution Generalization of a deep learning model for HER2 status predictions on H&E-stained whole slide images derived from 3 neoadjuvant clinical studies (2022) Haegele M, Mueller KR, Denkert C, Schneeweiss A, Sinn BV, Untch M, Van Mackelenbergh MT, et al. Conference contribution When to treat the pelvis in node-positive vulvar cancer: Results from the AGO-VOP.2 QS vulva study (2022) Hampl M, Jaeger A, Eulenburg C, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Conference contribution